LEXICON PHARMACEUTICALS, INC. (LXRX) › Operating IncomeLEXICON PHARMACEUTICALS, INC. (LXRX) — Operating IncomeAnnual figures by fiscal year, from SEC filings.2009: -$89.96M2010: -$95.72M2011: -$114.09M2012: -$108.42M2013: -$102.37M2014: -$100.37M2015: $1.47M2016: -$127.17M2017: -$130.62M2018: -$103.28M2019: $141.44M2020: -$47.80M2021: -$87.09M2022: -$100.76M2023: -$171.75M2024: -$197.12M2025: -$48.91M-$48.91M2009Operating Income (USD)2025Fiscal YearOperating IncomeChange YoY2025-$48.91M+75.2%2024-$197.12M-14.8%2023-$171.75M-70.5%2022-$100.76M-15.7%2021-$87.09M-82.2%2020-$47.80M-133.8%2019$141.44M+237.0%2018-$103.28M+20.9%2017-$130.62M-2.7%2016-$127.17M-8762.9%2015$1.47M+101.5%2014-$100.37M+2.0%2013-$102.37M+5.6%2012-$108.42M+5.0%2011-$114.09M-19.2%2010-$95.72M-6.4%2009-$89.96M—Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share